Thus, the cytokine IL-1, acting on its IL-1R1 receptor, plays an important role in mitigating obesity and MS, and understanding this pathway is important for the search for new therapeutic tools for obesity and MS. The gene discussed is IL1B; the disease is myeloid sarcoma.